The DOI matches its Crossref record; 64 of the 66 references it cites were found in a registry or an index.
The microtubule binding domain of tau protein
Abstract
Tau protein is a microtubule-associated protein implicated in the spatial and temporal specification of microtubules and has been found in the neurofibrillary tangles of Alzheimer's disease. Determination of tau protein structure has revealed three 18 amino acid repeated sequences hypothesized to be tubulin binding sites. Using tau cDNA clones from human fetal brain, we employed E. coli expression systems to synthesize tau protein and fragments of tau protein in order to identify the microtubule binding site. A fragment containing the three repeated sequences binds microtubules, while the amino-terminal half of the protein does not bind. Fragments containing two or one repeat are also capable of binding, indicating that the basic tubulin interacting unit is one repeat.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since tau binds to microtubules through C-terminal repeats within the microtubule-binding domain, 4R tau isoforms show a higher propensity to promote microtubule assembly compared to 3R tau isoforms [122, 123].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [122]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A new method for sequencing DNA.
Maxam, A. M., & Gilbert, W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.560 · Cited by 7,929
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Merril, C. R., Goldman, D. A., Sedman, S. A., & Ebert, M. H. (1981) · Science · doi:10.1126/science.6162199 · Cited by 2,933
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,491
Self-citationGoedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Dale, R. M. K., McClure, B., & Houchins, J. P. (1985) · Plasmid · doi:10.1016/0147-619x(85)90053-8 · Cited by 1,043
Cited by
Sorted by citations
Items 301–400 of 501
Disordered proteins in dementia
Ingelsson, M., & Hyman, B. T. (2002) · Annals of Medicine · doi:10.1080/078538902320322529 · Cited by 20
Collet, J., Ferhat, L., Pollard, H., de Pouplana, L. R., Charton, G., Bernard, A., Moreau, J., Ben‐Ari, Y., & Khrestchatisky, M. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01701.x · Cited by 19
Lemke, N., Melis, V., Lauer, D., Magbagbeolu, M., Neumann, B., Harrington, C. R., Riedel, G., Wischik, C. M., Theuring, F., & Schwab, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014890 · Cited by 15
Probing modifications of the neuronal cytoskeleton
Doering, L. C. (1993) · Molecular Neurobiology · doi:10.1007/bf02769179 · Cited by 18
Best, R. L., LaPointe, N. E., Liang, J., Ruan, K., Shade, M. F., Wilson, L., & Feinstein, S. C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009124 · Cited by 20
Hoffmann, R., Dawson, N. F., Wade, J. D., & Ötvös, L. (1997) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1997.tb01178.x · Cited by 17
Interaction of Tau construct K18 with model lipid membranes
Azouz, M., Feuillie, C., Lafleur, M., Molinari, M., & Lecomte, S. (2021) · Nanoscale Advances · doi:10.1039/d1na00055a · Cited by 16
Phosphorylation Pattern of tau Associated with Distinct Changes of the Growth Cone Cytoskeleton
Šimić, G., Diana, A., & Hof, P. R. (2003) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-55557-2_2 · Cited by 17
Safinya, C. R., Chung, P. J., Song, C., Li, Y., Ewert, K. K., & Choi, M. C. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.11.002 · Cited by 16
Solution structure of the microtubule‐targeting COS domain of MID1
Wright, K. M., Du, H., Dagnachew, M., & Massiah, M. A. (2016) · FEBS Journal · doi:10.1111/febs.13795 · Cited by 16
Mutreja, Y., & Gamblin, T. C. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.007 · Cited by 17
Discovery of Compounds That Will Prevent Tau Pathology
Kosik, K. S., Ahn, J. S., Stein, R. L., & Yeh, L.-A. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:261 · Cited by 16
Self-citationChung, C., Hong, Y.-M., Song, S.-M., Woo, H.-N., Choi, Y.-H., Rohn, T., & Jung, Y.-K. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.017 · Cited by 18
The Genetics of Frontotemporal Dementia
Haugarvoll, K., Wszołek, Z. K., & Hutton, M. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.002 · Cited by 16
Cross, D. C., Far�as, G. A., Dom�nguez, J., Ávila, J., & Maccioni, R. B. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925677 · Cited by 16
Ortmann, S., Marx, J., Lampe, C., Handrick, V., Ehnert, T.-M., Zinecker, S., Reimers, M., Bonas, U., & Erickson, J. L. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011263 · Cited by 15
Kohl, P. A., Song, C., Fletcher, B. J., Best, R. L., Tchounwou, C. K., Arceo, X. G., Chung, P. J., Miller, H. P., Wilson, L., Choi, M. C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46438-x · Cited by 16
The Role ofα-Synuclein and LRRK2 in Tau Phosphorylation
Kawakami, F., & Ichikawa, T. (2015) · Parkinson s Disease · doi:10.1155/2015/734746 · Cited by 15
Keyser, R. J., Oppon, E., Carr, J. A., & Bardien, S. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0591-z · Cited by 15
Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer’s Disease
Ivashko‐Pachima, Y., Zhou, L.-Y., Lei, P., & Gozes, I. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0715-x · Cited by 15
Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models
Sarkar, S. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0962-4 · Cited by 15
Tau-Like Proteins in the Nervous System of Goldfish
Liu, Y., Xia, J., Ma, D., Faber, D. S., & Fischer, I. (1997) · Neurochemical Research · doi:10.1023/a:1021914830872 · Cited by 14
Kitamura, T., Sugimori, K., Sudo, S., & Kobayashi, K. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00488.x · Cited by 14
Implications of the sequence similarities between tau and myelin basic protein
Karthigasan, J., Inouye, H., & Kirschner, D. A. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90111-6 · Cited by 14
Modeling tauopathy: a range of complementary approaches
Hall, G. F., & Yao, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.002 · Cited by 14
Development of an Assay to Screen for Inhibitors of Tau Phosphorylation by Cdk5
Ahn, J. S., Musacchio, A., Mapelli, M., Ni, J., Scinto, L. F. M., Stein, R. L., Kosik, K. S., & Yeh, L.-A. (2004) · SLAS DISCOVERY · doi:10.1177/1087057103260594 · Cited by 13
Self-citationKopel, J. J., Sehar, U., Choudhury, M., & Reddy, P. H. (2023) · Healthcare · doi:10.3390/healthcare11060868 · Cited by 15
The murine coronavirus as a model of trafficking and assembly of viral proteins in neural tissue
Kalicharran, K., & Dales, S. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10045-7 · Cited by 13
Review: Recent progress in frontotemporal lobar degeneration
Pickering-Brown, S. M. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01045.x · Cited by 13
Heberlein, K. R., Han, J., Straub, A. C., Best, A. K., Kaun, C., Wojta, J., & Isakson, B. E. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.246371 · Cited by 13
Molecular neuropathology of Alzheimer's disease:In situ hybridization studies
Goedert, M., & Spillantini, M. G. (1990) · Cellular and Molecular Neurobiology · doi:10.1007/bf00733642 · Cited by 13
da Costa, S. R., Wang, Y., Vilalta, P. M., Schönthal, A. H., & Hamm‐Alvarez, S. F. (2000) · Cell Motility and the Cytoskeleton · doi:10.1002/1097-0169(200012)47:4 · Cited by 11
Neurofibrillary Tangles, Dystrophic IMeurites (Curly Fibers), and Abnormal Phosphorylation of Tau
Mori, H., & Ihara, Y. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00670.x · Cited by 13
Beyond microtubule regulation: the multifaceted roles of tau in neuronal function and dysfunction
Bakota, L., Tulva, K., Trushina, N. I., & Brandt, R. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03947-1 · Cited by 12
Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
Majumder, M., & Dutta, D. (2024) · Cells · doi:10.3390/cells13131112 · Cited by 14
Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
Olesen, M. A., Villavicencio-Tejo, F., Cuevas-Espinoza, V., & Quintanilla, R. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102594 · Cited by 12
Tau Proteins Harboring Neurodegeneration-Linked Mutations Impair Kinesin Translocation in vitro
Yu, D., LaPointe, N. E., Guzman, E., Pessino, V., Wilson, L., Feinstein, S. C., & Valentine, M. T. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131274 · Cited by 12
Scialò, C., & Legname, G. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.008 · Cited by 12
N-Amination Converts Amyloidogenic Tau Peptides into Soluble Antagonists of Cellular Seeding
Makwana, K. M., Sarnowski, M. P., Miao, J., Lin, Y., & Valle, J. R. D. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00528 · Cited by 12
Sogawa, K., Okuda, R., In, Y., Ishida, T., Taniguchi, T., Minoura, K., & Tomoo, K. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs061 · Cited by 13
Assembly and bundling of marginal band microtubule protein: Role of tau
Sánchez, I., & Cohen, W. (1994) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970290106 · Cited by 12
Dingus, J., Obar, R. A., Hyams, J. S., Goedert, M., & Vallee, R. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55142-5 · Cited by 12
Giannakis, A., Konitsiotis, S., & Sioka, C. (2025) · Medicina · doi:10.3390/medicina61040701 · Cited by 12
Age-related Changes in Tau Expression in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Barańczyk‐Kuźma, A., Usarek, E., Kuźma‐Kozakiewicz, M., Kaźmierczak, B., Gajewska, B., Schwalenstöcker, B., & Ludolph, A. C. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9242-4 · Cited by 11
Les aspects génétiques de la maladie d’Alzheimer (Revue)
Kadmiri, N. E., Hamzi, K., Moutawakil, B. E., Slassi, I., & Nadifi, S. (2013) · Pathologie Biologie · doi:10.1016/j.patbio.2013.04.001 · Cited by 20
Shea, T. B., & Cressman, C. M. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(97)00044-0 · Cited by 11
Alzheimer's disease: Recent advances in molecular pathology and genetics
McLoughlin, D. M., & Lovestone, S. (1994) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930090602 · Cited by 11
Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation
Xia, Y., Bell, B. M., & Giasson, B. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098286 · Cited by 11
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
Haut, F., Argyrousi, E. K., & Arancio, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010259 · Cited by 11
Role of Oxygen Radicals in Alzheimer’s Disease: Focus on Tau Protein
Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2021) · Oxygen · doi:10.3390/oxygen1020010 · Cited by 11
Alhadidy, M. M., & Kanaan, N. M. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230596 · Cited by 10
Kuźma‐Kozakiewicz, M., Usarek, E., Ludolph, A. C., & Barańczyk‐Kuźma, A. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0436-z · Cited by 9
Structure of puromycin-sensitive aminopeptidase and polyglutamine binding
Madabushi, S., Chow, K. M., Song, E. S., Goswami, A., Hersh, L. B., & Rodgers, D. W. (2023) · PLOS ONE · doi:10.1371/journal.pone.0287086 · Cited by 9
Xia, Y., Nasif, L. H., & Giasson, B. I. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15358 · Cited by 9
Clinical and Molecular Aspects of Frontotemporal Dementia
Froelich-Fabre, S., Skoglund, L., Ostojic, J., Kilander, L., Lindau, M. P., Glaser, A., Basun, H., & Lannfelt, L. (2004) · Neurodegenerative Diseases · doi:10.1159/000080989 · Cited by 9
Li, Q., Callaghan, M., & Suprenant, K. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9271 · Cited by 9
Combs, C. K., Coleman, P. D., & O’Banion, M. K. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00019-4 · Cited by 9
Novella, I. S., Andreu, J. M., & Andreu, D. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81110-8 · Cited by 9
Bukhari, H., Nithianandam, V., Battaglia, R. A., Cicalo, A., Sarkar, S., Comjean, A., Hu, Y., Leventhal, M. J., Dong, X., & Feany, M. Β. (2024) · Genome Research · doi:10.1101/gr.278576.123 · Cited by 11
Cellular model of Alzheimer's disease — Relevance to therapeutic testing
Marwarha, G., & Ghribi, O. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.011 · Cited by 8
The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease
Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8
Tau-based therapies for Alzheimer’s disease: Promising novel neuroprotective approaches
Sayas, C. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00005-7 · Cited by 9
Cytoskeleton in abiotic stress signaling
Quezada-Rodríguez, E. H., Arthikala, M., & Nanjareddy, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90568-8.00016-x · Cited by 8
Tau Isoforms Expression in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Usarek, E., Kuźma‐Kozakiewicz, M., Schwalenstöcker, B., Kaźmierczak, B., Münch, C., Ludolph, A. C., & Barańczyk‐Kuźma, A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9057-3 · Cited by 8
Dan, A., & Chen, H. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13407 · Cited by 8
Localization of tau and other proteins of isolated marginal bands
Sánchez, I., & Cohen, W. (1994) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970270407 · Cited by 8
Buée, L., & Delacourte, A. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50023-8 · Cited by 8
Hussain, S. I., Muhammad, N., Shah, S. U. D., Fardous, F., Khan, S. A., Khan, N., Rehman, A. U., Siddique, M., Wasan, S. A., Niaz, R., et al. (2023) · BMC Neurology · doi:10.1186/s12883-023-03397-y · Cited by 7
Sahoo, T. A., Chand, J., Kandy, A. T., Shanish Antony, A., & Subramanian, G. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04399-7 · Cited by 9
Cho, G., Noh, M., Kang, B. Y., Ku, I.-W., Park, J., Hong, Y., Kim, M., & Kim, S. H. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0343 · Cited by 7
Selective dimerization of cysteines in glycopeptides and phosphopeptides
Hoffmann, R., & Ötvös, L. (1997) · Letters in Peptide Science · doi:10.1007/bf00127968 · Cited by 7
Safinya, C. R., Chung, P. J., Song, C., Li, Y., Miller, H. P., Choi, M. C., Raviv, U., Ewert, K. K., Wilson, L., & Feinstein, S. C. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b02208 · Cited by 7
Liu, H., Zhong, H., Liu, H., & Yao, X. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26196 · Cited by 7
Halverson, R. A., Chambers, C. B., & Muma, N. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7637 · Cited by 7
Functional domains on chemically modified tau protein
Far�as, G. A., Vial, C., & Maccioni, R. B. (1993) · Cellular and Molecular Neurobiology · doi:10.1007/bf00735373 · Cited by 7
The Biology and Pathobiology of Tau Protein
Hall, G. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-788-0_15 · Cited by 6
An emerging role for the gut microbiome in tauopathy
Zhu, Y., Self, W. K., & Holtzman, D. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00423 · Cited by 6
Atsmon‐Raz, Y., & Miller, Y. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201400162 · Cited by 6
Traveling the tau pathway: A personal account
Kosik, K. S. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s327 · Cited by 6
Self-citationThe Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
Medina, M., & Avil, J. (2011) · InTech eBooks · doi:10.5772/16879 · Cited by 7
Missense and Splice Site Mutations in Tau Associated with FTDP-17 Multiple Pathogenic Mechanisms
Hutton, M. L., Lovestone, S., Heutink, P., Pickering-Brown, S. M., & Yen, S. H. (2000) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04056-0_4 · Cited by 6
Introduction to the Tauopathies
Goedert, M. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch13 · Cited by 6
Liu, T., Ren, C., Guo, W., Zhang, X., Li, Y., Wang, Y., Zhang, Q., Chen, B., Dai, J., Yan, X., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117046 · Cited by 6
Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease
Navarro, N. V., Mundim, G. D. N., & Čudić, M. (2025) · Molecules · doi:10.3390/molecules30091895 · Cited by 5
Hartmann, C., Anskat, M., Ehrlich, M., Sterneckert, J. L., Pal, A., & Hermann, A. (2024) · Biomedicines · doi:10.3390/biomedicines12030641 · Cited by 5
Development of a Fluorescent High Throughput Assay for Tau Aggregation
Liu, M., Ni, J., Kosik, K. S., & Yeh, L.-A. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.609 · Cited by 5
Self-citationBush, M. S., Eagles, P. A. M., & Gordon‐Weeks, P. R. (1996) · The Cytoskeleton · doi:10.1016/s1874-6020(96)80009-7 · Cited by 5
Identification of a microtubule-binding domain sequence in pancreatic messenger RNAs
Neuville, P., Michalik, L., & Launay, J. (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(93)90038-3 · Cited by 5
The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
Wittnam, J. L. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3182 · Cited by 5
GSK-3β coordinates axonal microtubule organisation through Shot and TauPreprint
Voelzmann, A., Nuhu-Soso, L., Roof, A., Patel, S., Bennett, H. J., Adamson, A. D., Bentley, M., Evans, G. J. O., & Hahn, I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.08.611864 · Cited by 5
Ptprd deficiency promotes tau hyperphosphorylation and impairs cognitive function in aged mice
Foncea-Bitrán, A., Franchini, N., Tobar, I., Thienel, S., Retamal, I. N., Cancino, G. I., & Cornejo, F. (2025) · Biological Research · doi:10.1186/s40659-025-00607-4 · Cited by 4
Tchounwou, C. K., Jobanputra, A. J., Lasher, D., Fletcher, B. J., Jacinto, J., Bhaduri, A., Best, R. L., Fisher, W. S., Ewert, K. K., Li, Y., et al. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c02471 · Cited by 4
Passive Immunotherapy in Alzheimer’s Disease
Dolan, P. J., & Zago, W. M. (2018) · InTech eBooks · doi:10.5772/intechopen.76299 · Cited by 4
[Phosphorylation of tau and Alzheimer's disease].
García, T., & Jay, D. (2004) · PubMed · Cited by 4
Molecular Pathobiology of Alzheimer’s Disease
Harrington, C. R., & Wischik, C. M. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_13 · Cited by 4
Oyama, F., Shimada, H., Oyama, R., Titani, K., & Ihara, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08354.x · Cited by 4
Cytoplasmic domains of the myelin-associated glycoprotein
Kursula, P. (2000) · Cited by 4
Houzé, L., Dhénain, M., Lam, S., Petit, F., Haı̈k, S., Mouton‐Liger, F., Hugon, J., Dam, J., Paquet, C., Jockers, R., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01792-w · Cited by 3
Flavonoid-Based Derivatives for Modulating Various Targets of Alzheimer’s Disease
Pandey, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_11 · Cited by 3
Amyloid-motif-dependent tau self-assembly is modulated by isoform sequence context
Bali, S., Wydorski, P. M., Singh, R., Nuland, N. E. V., Wosztyl, A., Morgan, N., Perez, V. A., Chen, D., Chen, J., Rizo, J., et al. (2025) · Structure · doi:10.1016/j.str.2025.11.009 · Cited by 3
Metadata
- Authors
- Lee, G., Neve, R. L., & Kosik, K. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1989-06
- Volume
- 2
- Issue
- 6
- Pages
- 1615-1624
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1972355725
- Cited by
- 500
- References
- 66
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 13 · 2023: 19 · 2022: 12 · 2021: 19 · 2020: 14 · 2019: 17 · 2018: 13 · 2017: 13 · 2016: 8 · 2015: 12 · 2014: 13 · 2013: 13 · 2012: 13
- FWCI
- 14.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29gm039300-05, 5r01ag006601-13)
- National Institute on Aging (R01 AG06601-01)
- National Institute of General Medical Sciences (R29 GM39300-01)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, microtubule-binding site, microtubule-associated proteins, tubulin binding, neurofibrillary tangles, Alzheimer's disease, protein structure
- MeSH terms
- Amino Acid Sequence, Base Sequence, Binding Sites, DNA, Humans, Microtubule-Associated Proteins, Microtubules, Molecular Sequence Data, Protein Binding, Recombinant Fusion Proteins, Repetitive Sequences, Nucleic Acid, Sequence Homology, Nucleic Acid, Tubulin, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review